Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
This facility underwent an inspection from 15th to 19th July 2024 and has been classified as Voluntary Action Indicated
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
The USFDA inspection focused on evaluating the facility's adherence to global regulatory requirements and best practices
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
The company will take all necessary steps to work with USFDA towards earliest remediation of the above facility
Subscribe To Our Newsletter & Stay Updated
